Genovis ramps up in ADC technology: “An area where we’re seeing very strong interest”

With new products and an expanded licensing agreement in hand Genovis now has a partly new focus for its operations: ADCs – or antibody‑drug conjugates.

Asgard teaches tumours to self‑destruct – moving closer to clinical trials

Swedish biotech Asgard Therapeutics not only has an evocative name, but also a remarkably exciting approach to cancer treatment: getting tumour cells to reprogr...

National cord blood bank resumes collection

The collection of umbilical cord blood is now resuming during planned caesarean sections at Östra Hospital in Gothenburg. The blood remaining in the placenta an...

“BioArctic is Leqembi, but also much more”

What once began as a small Swedish biotech company has grown into a fully fledged pharmaceutical company with global reach. At the helm is Gunilla Osswald, who ...

Are you prepared for the updated ISO 10993 1:2025?

The latest edition of ISO 10993-1 reinforces the integration of biological evaluation with risk management, introduces updated approaches to exposure assessment...

The Versatile Solution for Quality Management and Data Analysis

Join our ZEISS PiWeb webinar on March 26.

Mercodia AB

Samuel Lagercrantz: ”Obesity, blockbusters and Swedish biotech”

The development of technologies to bypass the blood-brain barrier is particularly exciting right now, as it holds the potential to unlock new treatments for a r...

Internal audits based on ISO 13485 for medtech organizations

Are you ready to turn your internal audits into real improvements? Internal auditing isn’t just about compliance—it’s a strategic tool for driving development a...

Cell-free cartilage from Lund could pave the way for new bone transplants

Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...

Swedish drug development projects in Phase III – studies to keep an eye on

Developing new medicines is, as we know, a lengthy and uncertain process, and only a fraction of all projects ever reach late clinical phase. But it does happen...

Quretech granted a European patent for a new type of antibiotic

The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.

International medical graduates leave Sweden in high numbers

Three years after completing their studies, 46 percent of international doctoral students who graduated in the medical field had left the country. This is shown...

Dying man saved by artificial lung system

An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...

Lundbeck appoints Chief AI Officer

Danish pharmaceutical company Lundbeck has appointed Markus Kede as Chief AI Officer. He will join the Executive Leadership Team and report to President and CEO Charl van Zyl.

Finland leads the way in the hunt for international top researchers

Several Nordic initiatives are currently under way to recruit international top researchers. Finland is making its largest national investment ever in attractin...

Study: Autism as common in girls as in boys

Autism may be just as common in girls as in boys, but girls are diagnosed significantly later and less often during childhood, according to a large Swedish registry study.

Multiplex Immunofluorescence

New protocol for efficient generation of seven-color, whole slide imaging with ZEISS Axioscan.

Gene therapies on clinical hold after tumour found in five‑year‑old

The development of a brain tumour in a study participant has led the FDA to temporarily halt two ongoing gene therapy programs. The affected company, Regenxbio,...

How Microscopy Can Help Families Grow

Advanced microscopy solutions can help bypass challenges and natural barriers of conception.

ISO 20417 has been updated – what device manufacturers should consider

The new edition of ISO 20417 has been published, further clarifying expectations for information supplied with medical devices. Although not yet harmonized, the...

FDA leaders seek to scrap two-study requirement

A single pivotal study may be sufficient to secure approval for a new medicine in the United States. That is the message delivered by FDA Commissioner Marty Mak...

“The US matters most – even in times of turbulence”

Tariffs, geopolitical uncertainty and rapidly changing trade conditions mean that Swedish life science companies need more routes into global markets – and fast...

Acne medication may be the solution when hair starts falling out

A treatment originally developed for acne has shown remarkable Phase III results in a completely different area: male-pattern hair loss.